Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Research article

Prevalence of metabolic syndrome in Murcia Region, a southern European Mediterranean area with low cardiovascular risk and high obesity

Authors: Diana Gavrila, Diego Salmerón, José-Manuel Egea-Caparrós, José M Huerta, Alfonso Pérez-Martínez, Carmen Navarro, María-José Tormo

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

Metabolic syndrome (MS) is associated with subsequent appearance of diabetes and cardiovascular disease. As compared to other Spanish regions, Murcia (southern Spain) registers increased obesity as well as cardiovascular morbidity and mortality. The aim of this study was to assess the prevalence of MS and its components, awareness of obesity as a health risk and associated lifestyles.

Methods

A population-based, cross-sectional study was conducted in 2003, covering a sample of 1555 individuals 20 years and over. MS was defined according to the Revised National Cholesterol Education Program Adult Treatment Panel III (R-ATPIII), International Diabetes Federation (IDF) and Joint Interim Statement (JIS) criteria. Both low (94/80) and high (102/88) waist circumference (WC) thresholds were considered.

Results

Prevalence of MS was 27.2% (95%CI: 25.2-29.2), 32.2% (95%CI: 30.1-34.3) and 33.2% (95%CI: 31.2-35.3) according to the R-ATPIII, IDF and JIS94/80 respectively. It increased with age until reaching 52.6% (R-ATPIII) or 60.3% (JIS94/80) among persons aged 70 years and over, and was higher in persons with little or no formal education (51.7% R-ATPIII, 57.3% JIS94/80). The most common risk factors were hypertension (46.6%) and central obesity (40.7% and 66.1% according to high and low WC cut-off points respectively). Although most persons were aware that obesity increased health risks, regular exercise was very unusual (13.0% centrally obese, 27.2% non-centrally obese). Adherence to dietary recommendations was similar among centrally obese and non-centrally obese subjects.

Conclusions

Prevalence of MS is high in our population, is comparable to that found in northern Europe and varies with the definition used. Adherence to preventive recommendations and to adequate weight promotion is very low. In the absence of a specific treatment for MS, integrated intervention based on a sustained increase in physical activity and changes in diet should be reinforced.
Appendix
Available only for authorised users
Literature
1.
Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005, 28: 1769-1778. 10.2337/diacare.28.7.1769.CrossRefPubMed
2.
Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988, 37: 1595-1607. 10.2337/diabetes.37.12.1595.CrossRefPubMed
3.
Alberti KG, Zimmet P, Shaw J: Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006, 23: 469-480. 10.1111/j.1464-5491.2006.01858.x.CrossRefPubMed
4.
Regidor E, Gutiérrez-Fisac JL, Alfaro M: Indicadores de Salud 2009. Evolución de los indicadores del estado de salud en España y su magnitud en el contexto de la Unión Europea. 2009, Madrid: Ministerio de Sanidad y Política Social, 4-6-2010
5.
Marrugat J, Elosua R, Aldasoro E, Tormo MJ, Vanaclocha H, Segura A, et al: Regional variability in population acute myocardial infarction cumulative incidence and mortality rates in Spain 1997 and 1998. Eur J Epidemiol. 2004, 19: 831-839.CrossRefPubMed
6.
Huerta JM, Tormo MJ, Gavrila D, Navarro C: Cardiovascular risk estimated after 13 years of follow-up in a low-incidence Mediterranean region with high-prevalence of cardiovascular risk factors. BMC Public Health. 2010, 10: 640-10.1186/1471-2458-10-640.CrossRefPubMedPubMedCentral
7.
Valverde JC, Tormo MJ, Navarro C, Rodriguez-Barranco M, Marco R, Egea JM, et al: Prevalence of diabetes in Murcia (Spain): a Mediterranean area characterised by obesity. Diabetes Res Clin Pract. 2006, 71: 202-209. 10.1016/j.diabres.2005.06.009.CrossRefPubMed
8.
Agudo A, Slimani N, Ocke MC, Naska A, Miller AB, Kroke A, et al: Consumption of vegetables, fruit and other plant foods in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts from 10 European countries. Public Health Nutr. 2002, 5: 1179-1196. 10.1079/PHN2002398.CrossRefPubMed
9.
Linseisen J, Bergstrom E, Gafa L, Gonzalez CA, Thiebaut A, Trichopoulou A, et al: Consumption of added fats and oils in the European Prospective Investigation into Cancer and Nutrition (EPIC) centres across 10 European countries as assessed by 24-hour dietary recalls. Public Health Nutr. 2002, 5: 1227-1242. 10.1079/PHN2002401.CrossRefPubMed
10.
Sieri S, Agudo A, Kesse E, Klipstein-Grobusch K, San-Jose B, Welch AA, et al: Patterns of alcohol consumption in 10 European countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) project. Public Health Nutr. 2002, 5: 1287-1296. 10.1079/PHN2002405.CrossRefPubMed
11.
Ryan M, McInerney D, Owens D, Collins P, Johnson A, Tomkin GH: Diabetes and the Mediterranean diet: a beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium-dependent vasoreactivity. QJM. 2000, 93: 85-91. 10.1093/qjmed/93.2.85.CrossRefPubMed
12.
Martinez-Ros MT, Tormo MJ, Navarro C, Chirlaque MD, Perez-Flores D: Extremely high prevalence of overweight and obesity in Murcia, a Mediterranean region in south-east Spain. Int J Obes Relat Metab Disord. 2001, 25: 1372-1380. 10.1038/sj.ijo.0801684.CrossRefPubMed
13.
Haftenberger M, Lahmann PH, Panico S, Gonzalez CA, Seidell JC, Boeing H, et al: Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 2002, 5: 1147-1162. 10.1079/PHN2002396.CrossRefPubMed
14.
Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation [see comments]. Diabet Med. 1998, 15: 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed
15.
Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, et al: Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002, 28: 364-376.PubMed
16.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed
17.
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed
18.
Pols MA, Peeters PH, Ocke MC, Slimani N, Bueno-de-Mesquita HB, Collette HJ: Estimation of reproducibility and relative validity of the questions included in the EPIC Physical Activity Questionnaire. Int J Epidemiol. 1997, 26 (Suppl 1): S181-9. S181-S189CrossRefPubMed
19.
Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al: Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 2007, 116: 1081-1093.CrossRefPubMed
20.
Willett WC, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, et al: Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr. 1995, 61: 1402S-1406S.PubMed
21.
WHO Regional Office for Europe: Measuring obesity. Classification and description of anthropometric data. Report on a WHO Consultation on the Epidemiology of Obesity. 1988, Copenhagen, Ref Type: Report
22.
Keil U, Kuulasmaa K: WHO MONICA Project: risk factors [published erratum appears in Int J Epidemiol 1990 Sep;19(3):following 775]. Int J Epidemiol. 1989, 18: S46-S55.CrossRefPubMed
23.
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al: European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Atherosclerosis. 2007, 194: 1-45. 10.1016/j.atherosclerosis.2007.08.024.CrossRefPubMed
24.
Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008, 31 (Suppl 1): S55-S60.
25.
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997, 20: 1183-1197.
26.
Qiao Q: Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia. 2006, 49: 2837-2846.CrossRefPubMed
27.
Halldin M, Rosell M, de FU, Hellenius ML: The metabolic syndrome: prevalence and association to leisure-time and work-related physical activity in 60-year-old men and women. Nutr Metab Cardiovasc Dis. 2007, 17: 349-357. 10.1016/j.numecd.2006.01.002.CrossRefPubMed
28.
Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA: Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 2007, 7: 220-10.1186/1471-2458-7-220.CrossRefPubMedPubMedCentral
29.
Adams RJ, Appleton S, Wilson DH, Taylor AW, Dal GE, Chittleborough C, et al: Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care. 2005, 28: 2777-2779. 10.2337/diacare.28.11.2777.CrossRefPubMed
30.
Sidorenkov O, Nilssen O, Brenn T, Martiushov S, Arkhipovsky VL, Grjibovski AM: Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study. BMC Public Health. 2010, 10: 23-10.1186/1471-2458-10-23.CrossRefPubMedPubMedCentral
31.
Miccoli R, Bianchi C, Odoguardi L, Penno G, Caricato F, Giovannitti MG, et al: Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr Metab Cardiovasc Dis. 2005, 15: 250-254. 10.1016/j.numecd.2004.09.002.CrossRefPubMed
32.
Boronat M, Chirino R, Varillas VF, Saavedra P, Marrero D, Fabregas M, et al: Prevalence of the metabolic syndrome in the island of Gran Canaria: comparison of three major diagnostic proposals. Diabet Med. 2005, 22: 1751-1756. 10.1111/j.1464-5491.2005.01745.x.CrossRefPubMed
33.
Martinez-Larrad MT, Fernandez-Perez C, Gonzalez-Sanchez JL, Lopez A, Fernandez-Alvarez J, Riviriego J, et al: [Prevalence of the metabolic syndrome (ATP-III criteria). Population-based study of rural and urban areas in the Spanish province of Segovia]. Med Clin (Barc). 2005, 125: 481-486. 10.1157/13080210.CrossRef
34.
Martinez CJ, Franch NJ, Romero OJ, Canovas DC, Gallardo MA, Lopez Yepes ML: [Predictive capacity of the diagnostic criteria of metabolic syndrome on the insulin-resistance and the coronary risk]. Med Clin (Barc). 2007, 129: 601-606. 10.1157/13111806.CrossRef
35.
Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care. 2005, 28: 2745-2749. 10.2337/diacare.28.11.2745.CrossRefPubMed
36.
Vega GL, Barlow CE, Grundy SM: Prevalence of the metabolic syndrome as influenced by the measure of obesity employed. Am J Cardiol. 2010, 105: 1306-1312. 10.1016/j.amjcard.2009.12.048.CrossRefPubMed
37.
Alkerwi A, Donneau AF, Sauvageot N, Lair ML, Scheen A, Albert A, et al: Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study. BMC Public Health. 2011, 11: 4-10.1186/1471-2458-11-4.CrossRefPubMedPubMedCentral
38.
Boronat M, Saavedra P, Varillas VF, Wagner AM, Lopez-Plasencia Y, Alberiche MP, et al: Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program. Nutr Metab Cardiovasc Dis. 2009, 19: 417-422. 10.1016/j.numecd.2008.07.010.CrossRefPubMed
39.
Xu WH, Ruan XN, Fu XJ, Zhu QL, Zhang H, Bai Y, et al: Prevalence of the metabolic syndrome in Pudong New Area of Shanghai using three proposed definitions among Chinese adults. BMC Public Health. 2010, 10: 246-10.1186/1471-2458-10-246.CrossRefPubMedPubMedCentral
40.
Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P: Prevalence of the metabolic syndrome among Omani adults. Diabetes Care. 2003, 26: 1781-1785. 10.2337/diacare.26.6.1781.CrossRefPubMed
41.
Livingstone MB, Black AE: Markers of the validity of reported energy intake. J Nutr. 2003, 133 (Suppl 3): 895S-920S.PubMed
Metadata
Title
Prevalence of metabolic syndrome in Murcia Region, a southern European Mediterranean area with low cardiovascular risk and high obesity
Authors
Diana Gavrila
Diego Salmerón
José-Manuel Egea-Caparrós
José M Huerta
Alfonso Pérez-Martínez
Carmen Navarro
María-José Tormo
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-562

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue

Research article

Burden of disease in Thailand: changes in health gap between 1999 and 2004

Research article

Association of daily tar and nicotine intake with incident myocardial infarction: Results from the population-based MONICA/KORA Augsburg Cohort Study 1984 - 2002

Research article

Use and perceived helpfulness of smoking cessation methods: results from a population survey of recent quitters

Research article

A pilot study of Aboriginal health promotion from an ecological perspective

Correspondence

GET WELL: an automated surveillance system for gaining new epidemiological knowledge

Research article

The Big Drink Debate: perceptions of the impact of price on alcohol consumption from a large scale cross-sectional convenience survey in north west England